Inspire Trust Company’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-16,525
Closed -$687K 116
2024
Q4
$687K Hold
16,525
0.18% 110
2024
Q3
$1.1M Buy
16,525
+7,000
+73% +$643K 0.3% 96
2024
Q2
$1.13M Buy
9,525
+1,500
+19% +$190K 0.37% 88
2024
Q1
$855K Buy
8,025
+2,900
+57% +$292K 0.48% 77
2023
Q4
$510K Buy
+5,125
New +$431K 0.53% 64

Other funds holding MRNA

Inspire Trust Company's MRNA Position: Q1 2025 in Review

Inspire Trust Company sold out of Moderna (MRNA) in Q1 2025, closing a stake of 16,525 shares — an estimated $687K sold.

Inspire Trust Company first reported a position in MRNA in Q4 2023 and held it in 5 quarters. The position peaked at $1.13M in Q2 2024. 693 funds tracked by Wall St. Rank hold MRNA as of Q1 2025.

  • Inspire Trust Company reported no remaining Moderna position as of Q1 2025 after selling out during the quarter.
  • Inspire Trust Company sold 16,525 Moderna shares in Q1 2025, an estimated $687K.
  • Inspire Trust Company first reported a position in Moderna in Q4 2023 and held it in 5 quarters.
  • Inspire Trust Company's Moderna position peaked at $1.13M in Q2 2024.
  • 693 funds tracked by Wall St. Rank held Moderna as of Q1 2025.

Based on Inspire Trust Company's 13F filing for Q1 2025, filed 13 May 2025.